Wells Fargo & Company Black Diamond Therapeutics, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 14,187 shares of BDTX stock, worth $30,927. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,187

Previous 13,718 3.42%

Holding current value

$30,927

Previous $63,000 3.17%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$4.2 - $6.58 $1,969 - $3,086	469 Added 3.42%	14,187 $61,000
Q2 2024 Aug 13, 2024	BUY	$4.65 - $7.39 $62,491 - $99,314	13,439 Added 4816.85%	13,718 $63,000
Q1 2024 May 10, 2024	BUY	$2.67 - $5.74 $13 - $28	5 Added 1.82%	279 $1,000
Q4 2023 Feb 09, 2024	SELL	$1.77 - $3.03 $152 - $260	-86 Reduced 23.89%	274 $0
Q3 2023 Nov 13, 2023	BUY	$2.87 - $4.99 $324 - $563	113 Added 45.75%	360 $1,000
Q2 2023 Aug 15, 2023	SELL	$1.43 - $6.18 $563 - $2,434	-394 Reduced 61.47%	247 $1,000
Q1 2023 May 12, 2023	BUY	$1.35 - $3.14 $542 - $1,262	402 Added 168.2%	641 $1,000
Q4 2022 Feb 13, 2023	SELL	$1.27 - $2.51 $629 - $1,244	-496 Reduced 67.48%	239 $0
Q3 2022 Nov 14, 2022	SELL	$1.68 - $4.01 $26 - $64	-16 Reduced 2.13%	735 $1,000
Q2 2022 Aug 12, 2022	SELL	$1.5 - $3.63 $1,768 - $4,279	-1,179 Reduced 61.09%	751 $1,000
Q1 2022 May 16, 2022	SELL	$2.66 - $5.61 $21,479 - $45,300	-8,075 Reduced 80.71%	1,930 $6,000
Q4 2021 Feb 14, 2022	SELL	$5.18 - $8.48 $18,974 - $31,062	-3,663 Reduced 26.8%	10,005 $53,000
Q3 2021 Nov 15, 2021	BUY	$8.46 - $12.42 $2,444 - $3,589	289 Added 2.16%	13,668 $115,000
Q2 2021 Aug 16, 2021	SELL	$12.19 - $28.17 $8 Million - $18.5 Million	-656,475 Reduced 98.0%	13,379 $163,000
Q1 2021 May 13, 2021	BUY	$22.23 - $34.75 $138,292 - $216,179	6,221 Added 0.94%	669,854 $16.3 Million
Q4 2020 Feb 09, 2021	BUY	$29.47 - $35.0 $5.93 Million - $7.04 Million	201,246 Added 43.52%	663,633 $21.3 Million
Q3 2020 Nov 05, 2020	BUY	$26.17 - $43.07 $4.65 Million - $7.66 Million	177,855 Added 62.51%	462,387 $14 Million
Q2 2020 Aug 13, 2020	BUY	$22.3 - $44.8 $5.94 Million - $11.9 Million	266,336 Added 1463.71%	284,532 $12 Million
Q1 2020 May 14, 2020	BUY	$18.18 - $39.48 $330,803 - $718,378	18,196 New	18,196 $454,000

Others Institutions Holding BDTX

# of Institutions

117

Shares Held

48.8M

Call Options Held

1.84M

Put Options Held

1.93M

View Full List

About Black Diamond Therapeutics, Inc.

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $79.2M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

More about BDTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Black Diamond Therapeutics, Inc. Transaction History